Literature DB >> 7835442

The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease.

H B Hoh1, R D Laitt, C Wakeley, J Kabala, P Goddard, M J Potts, R A Harrad.   

Abstract

Nineteen patients with thyroid eye disease were examined with magnetic resonance imaging using the Short Tau Inversion Recovery (STIR) sequence and compared with normal controls. The Signal Intensity Ratio (SIR) of each of the four recti was obtained by comparison with the signal intensity of the adjacent temporalis muscle. The SIR was compared with disease activity assessed using Werner's grading system, a clinical inflammatory score, and the range of extraocular movements. Results show that a high SIR is associated with a high index of disease activity. This technique is likely to prove useful in assessing disease activity and planning the management of thyroid eye disease, particularly with respect to immunosuppression.

Entities:  

Mesh:

Year:  1994        PMID: 7835442     DOI: 10.1038/eye.1994.126

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  9 in total

1.  Flashing lights in thyroid eye disease: a new symptom described and (possibly) explained.

Authors:  J J Danks; R A Harrad
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

2.  Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Katsutaro Morino; Satoshi Ugi; Yoshihiko Nishio; Hiroshi Maegawa; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2014-12-03       Impact factor: 2.447

3.  Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy.

Authors:  Y Kaichi; K Tanitame; H Itakura; H Ohno; M Yoneda; Y Takahashi; Y Akiyama; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

4.  Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves' orbitopathy and analysis on who requires additional therapy.

Authors:  Theodora Tsirouki; Alexandra Bargiota; Stelios Tigas; Agathi Vasileiou; Eftichia Kapsalaki; Zoe Giotaki; Ioannis Asproudis; Agathokles Tsatsoulis; Georgios Koukoulis; Evangelia E Tsironi
Journal:  Clin Ophthalmol       Date:  2016-11-17

5.  Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.

Authors:  Tomoaki Higashiyama; Maki Iwasa; Masahito Ohji
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

6.  Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence.

Authors:  Qian Ge; Xiaohui Zhang; Jian Long; Chun Liu; Lu Wang; Yao Fan; Qian Huang; Ning Yao
Journal:  BMC Endocr Disord       Date:  2021-11-13       Impact factor: 2.763

7.  Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.

Authors:  Annamaria Erdei; Annamaria Gazdag; Bernadett Ujhelyi; Edit B Nagy; Ervin Berenyi; Eszter Berta; Zita Steiber; Sandor Barna; Emese Mezosi; Miklos Bodor; Endre V Nagy
Journal:  Eur Thyroid J       Date:  2022-08-11

8.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

9.  Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Masahito Ohji
Journal:  Clin Ophthalmol       Date:  2016-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.